A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients
Clinical trial NCT07635316 · RECRUITING
Trial details
- NCT number
- NCT07635316
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-12
- Primary completion
- 2027-02-25
- Enrollment
- 4023
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.